NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

As you pointed out this was 2 years ago and it sounded to me that he referred to CarT around the time he was mentioning low percentage response. Multiple attempts/trials have failed so dcvax-l has had to deal with the challenges this doctor enumerated and to be successful I think dcvax has to have done enough better across multiple dimensions, or put more simply the secret sauce of process and techniques combine well enough to achieve improvement over SOC and other failed vaccines.

I’m not a medical doctor nor researcher in this field so this is just imho.